These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12497049)

  • 1. A population-based study on radical prostatectomy in France.
    Soulié M; Villers A; Grosclaude P; Ménegoz F; Schaffer P; Mace-Lesec'h J; Sauvage-Machelard M; Grand A
    Prostate Cancer Prostatic Dis; 2001; 4(2):118-123. PubMed ID: 12497049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variations of the practice of radical prostatectomy in France].
    Soulié M; Grosclaude P; Villers A; Menegoz F; Schaffer P; Mace-Lesec'h J; Molinier L; Sauvage-Machelard M; Grand A
    Prog Urol; 2001 Feb; 11(1):49-55. PubMed ID: 11296646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study on management of prostate cancer in four regions of France.
    Soulié M; Grosclaude P; Villers A; Ménegoz F; Schaffer P; Mace-Lesec'h J; Molinier L; Sauvage-Machelard M
    Prostate Cancer Prostatic Dis; 2001; 4(3):154-160. PubMed ID: 12497034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer of the prostate in France: results of the survey CCAFU-FRANCIM].
    Soulié M; Villers A; Grosclaude P; Menegoz F; Schaffer P; Mace-Lesec'h J; Sauvage-Machelard M; Molinier L; Grand A
    Prog Urol; 2001 Jun; 11(3):478-85. PubMed ID: 11512461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A; Murai M; Baba S; Ogawa O; Tsukamoto T; Niwakawa M; Tobisu K; Kinukawa N; Naito S
    BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
    J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate cancer in Isère and Tarn (France) between 1985 and 1995: evolution of therapeutic indications].
    Chirpaz E; Ménégoz F; Grosclaude P; Colonna M; Bénard E; Rambeaud JJ
    Bull Cancer; 1998 Dec; 85(12):1049-54. PubMed ID: 9917556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcomes of active surveillance for localized prostate cancer.
    Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
    BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of persistently detectable PSA after radical prostatectomy.
    Naselli A; Introini C; Andreatta R; Spina B; Truini M; Puppo P
    Int J Urol; 2009 Jan; 16(1):82-6. PubMed ID: 19054168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.
    Zlotta AR; Roumeguère T; Ravery V; Hoffmann P; Montorsi F; Türkeri L; Dobrovrits M; Scattoni V; Ekane S; Bollens R; Vanden Bossche M; Djavan B; Boccon-Gibod L; Schulman CC;
    Eur Urol; 2004 Jul; 46(1):42-9. PubMed ID: 15183546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of prostate cancer detection and management in China and in France.
    Peyromaure EM; Mao K; Sun Y; Xia S; Jiang N; Zhang S; Wang G; Liu Z; Debré B
    Can J Urol; 2009 Feb; 16(1):4472-7. PubMed ID: 19222885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Boorjian SA; Bianco FJ; Scardino PT; Eastham JA
    BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.